Page 100 - TD-3-3

Tumor Discovery PTMAP5–hsa-miR-22-3p–KIF2C axis in HCC development

47. Kazazian K, Go C, Wu H, et al. Plk4 promotes cancer doi: 10.26355/eurrev_202004_20821
invasion and metastasis through Arp2/3 complex regulation 51. Locy H, de Mey S, de Mey W, De Ridder M, Thielemans K,
of the actin cytoskeleton. Cancer Res. 2017;77(2):434-447.
Maenhout SK. Immunomodulation of the tumor
doi: 10.1158/0008-5472.CAN-16-2060 microenvironment: Turn foe into friend. Front Immunol.
2018;9:2909.
48. Chen YG, Satpathy AT, Chang HY. Gene regulation in the
immune system by long noncoding RNAs. Nat Immunol. doi: 10.3389/fimmu.2018.02909
2017;18(9):962-972.
52. Mooradian MJ, Sullivan RJ. Immunomodulatory effects of
doi: 10.1038/ni.3771 current cancer treatment and the consequences for follow-up
immunotherapeutics. Future Oncol. 2017;13(18):1649-1663.
49. Ghafouri-Fard S, Taheri M. Long non-coding RNA signature
in gastric cancer. Exp Mol Pathol. 2020;113:104365. doi: 10.2217/fon-2017-0117
doi: 10.1016/j.yexmp.2019.104365 53. Petitprez F, Meylan M, de Reyniès A, Sautès-Fridman C,
Fridman WH. The tumor microenvironment in the response
50. Hu PA, Miao YY, Yu S, Guo N. Long non-coding RNA
SNHG5 promotes human hepatocellular carcinoma to immune checkpoint blockade therapies. Front Immunol.
progression by regulating miR-363-3p/RNF38 axis. Eur Rev 2020;11:784.
Med Pharmacol Sci. 2020;24(7):3592-3604. doi: 10.3389/fimmu.2020.00784

Volume 3 Issue 3 (2024) 24 doi: 10.36922/td.2846